Simulations Plus, Inc. filings document a California operating company that reports as a provider of model-informed and AI-accelerated drug development software and services. Its 8-K reports furnish quarterly financial results, investor presentation materials, preliminary operating updates, guidance-related disclosures, and Regulation FD information tied to its software and services business.
The company’s proxy and governance filings cover annual meeting voting, director and executive compensation matters, shareholder approval of amendments to the 2021 Equity Incentive Plan, and common-stock authorization for equity awards. Other material-event reports document executive employment agreements, changes in the independent registered public accounting firm, internal-control and segment-reporting matters, and related audit committee actions.
Simulations Plus, Inc. (SLP) reported an insider transaction on Form 4. Director John Kenneth Paglia acquired 1,771 shares of common stock on November 3, 2025, described as “stock granted as independent director compensation” under the company’s 2021 Equity Incentive Plan.
The filing lists a transaction price of $0 per share for the grant. After this award, Paglia beneficially owned 10,696 shares, held directly.
Simulations Plus (SLP) director Sharlene Evans reported an equity grant on Form 4. On 11/03/2025, she acquired 1,771 shares of common stock at $0 as independent director compensation under the company’s 2021 Equity Incentive Plan.
Following the grant, Evans beneficially owns 13,280 shares, held directly. This filing reflects routine director compensation rather than an open‑market purchase.
Simulations Plus, Inc. (SLP) furnished an 8-K announcing a press release with preliminary operational results for its fourth fiscal quarter ended August 31, 2025, and providing guidance and estimates for the fiscal year ending August 31, 2026.
The information under Items 2.02 and 7.01, and Exhibit 99.1, is furnished and not filed, and is not incorporated by reference except as expressly stated. The company also included a customary caution regarding forward-looking statements.
Simulations Plus (SLP) reported an insider equity grant: Chief Executive Officer Shawn O’Connor received 50,000 stock options to purchase common stock at an exercise price of $16.02 per share on 10/16/2025. The options expire on 10/15/2035 and were reported as a direct holding following the transaction.
The award vests over three years: 40% on the first anniversary, then 30% on each of the second and third anniversaries. The filing reflects a routine compensation grant under which the number of derivative securities beneficially owned after the transaction is 50,000.
Simulations Plus (SLP) reported an insider equity grant: its EVP/CFO received 32,500 stock options at an exercise price of $16.02 on 10/16/2025.
The options expire on 10/15/2035 and vest in four equal annual installments, with one fourth vesting on each anniversary of the grant date. Following this grant, the reporting person holds 32,500 derivative securities directly.
Simulations Plus (SLP) officer Jill Fiedler‑Kelly, President, Services Solutions, reported a grant of 27,500 stock options on 10/16/2025 with an exercise price of $16.02 per share.
The options vest in four equal annual installments on each anniversary of the grant date and expire on 10/15/2035. Following the transaction, 27,500 derivative securities were beneficially owned directly.
Simulations Plus, Inc. (SLP) reported an insider equity award. A Form 4 discloses that Chief Revenue Officer John Anthony DiBella received stock options to purchase 27,500 shares at an exercise price of $16.02 on 10/16/2025.
The options expire on 10/15/2035 and vest in four equal annual installments, with one-fourth vesting on each anniversary of the grant date. Following the reported transaction, 27,500 derivative securities are beneficially owned directly.
Form 144 notice for Simulations Plus, Inc. (SLP): An insider proposes to sell 20,000 shares of Common stock through Morgan Stanley Smith Barney on 10/01/2025 with an aggregate market value of $301,400.00. The shares were originally acquired as Founders Shares from the issuer on 07/01/1996. The filing reports 20,127,110 shares outstanding for the class and indicates no securities sold in the past three months by the reporting person. The filer certifies no undisclosed material adverse information and follows the Rule 144 notice format for proposed sale reporting.
Simulations Plus director Lisa LaVange reported the sale of 867 shares of the company's common stock on 09/02/2025. The Form 4 states the shares were sold in a single transaction at $14.10 per share and that the sale was effected automatically pursuant to a Rule 10b5-1 trading plan. Following the reported transaction, Ms. LaVange beneficially owns 9,063 shares and holds those shares in a direct ownership form. The filing indicates the reporter is a director and the Form 4 was executed by an attorney-in-fact on 09/04/2025.